PKM and acute lymphoblastic leukemia: Our results illustrate this generalized concept with several lines of evidence, including TcB shift from low to high-TCB in ALL, reversibility in canine lymphoma, and transcriptional lag in SUDHL4 cells with BKM120 treatment, all indicative of cancer progression.